Log In
BCIQ
Print this Print this
 

Staccato alprazolam (AZ-002)

  Manage Alerts
Collapse Summary General Information
Company Grupo Ferrer Internacional S.A.
DescriptionAlprazolam, a GABA receptor modulating benzodiazepine, delivered via the Staccato system inhaler
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSeizures
Indication DetailsTreat acute repetitive seizures in epileptics
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$54.6M

$19.6M

$35.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/21/2016

$54.6M

$19.6M

$35.0M

Get a free BioCentury trial today